Covant Therapeutics

0 followers


Operator of a covalent drug discovery company intended to create novel therapeutics by using covalency to imprint and regulate proteins. The company applies cutting-edge capabilities and expertise in chemistry, quantitative proteomics, translational sciences, and deep learning, enabling clients to t... Read more

Employees

11-50

Links


Org chart

Ivan Cornella-Taracido
Chief Scientific Officer
Collapse
Jason Imbriglio
Co-founder Covant Therapeutics, SVP - Head Of Drug Discovery
Filippos Kottakis
Principal Investigator, Biology

Teams

This company has no teams yet